SCHEMBL20968796

SCHEMBL20968796

CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)C(C)(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.68
FAAH O00519 4/20 0.68
MAPT P10636 2/20 0.68
BLM P54132 2/20 0.68
PLA2G4B P0C869 1/20 0.68
PLA2G4A P47712 1/20 0.68
MGLL Q99685 1/20 0.68
PLA2G4C Q9UP65 1/20 0.68
PPARG P37231 5/20 0.66
F7 P08709 4/20 0.66
F3 P13726 4/20 0.66
PPARD Q03181 4/20 0.66
PPARA Q07869 4/20 0.66
FFAR1 O14842 3/20 0.66
PTGS1 P23219 2/20 0.66
L3MBTL1 Q9Y468 2/20 0.66
ESR1 P03372 1/20 0.66
SRD5A2 P31213 1/20 0.66
CASP6 P55212 1/20 0.66
KDM4E B2RXH2 4/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20968838 0.98 ALDH1A1 (0.67) ALDH1A1FAAHMAPTBLMPLA2G4B
SCHEMBL22525234 0.96 ALDH1A1 (0.73) ALDH1A1FAAHMAPTBLMPLA2G4B
SCHEMBL22525183 0.93 FAAH (0.71) FAAHMAPTBLMPPARGF7
SCHEMBL25834781 0.93 FAAH (0.71) FAAHMAPTBLMPPARGF7
SCHEMBL25835999 0.93 FAAH (0.71) FAAHMAPTBLMPPARGF7
SCHEMBL23772133 0.93 FAAH (0.71) FAAHMAPTBLMPPARGF7
SCHEMBL22525273 0.93 FAAH (0.71) FAAHMAPTBLMPPARGF7
SCHEMBL114309 0.93 FAAH (0.71) FAAHMAPTBLMPPARGF7
SCHEMBL25836005 0.93 FAAH (0.71) FAAHMAPTBLMPPARGF7
SCHEMBL22525182 0.91 ALDH1A1 (0.57) ALDH1A1FAAHMAPTBLMPLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295617-A1 METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS WAVE LIFE SCIENCES LTD. (SG) 2023-09-21 US disclosed
US-20230295617-A1 METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS WAVE LIFE SCIENCES LTD. (SG) 2023-09-21 US disclosed
US-20190249173-A1 METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS WAVE LIFE SCIENCES LTD. (SG) 2019-08-15 US disclosed
US-20190127733-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2019-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127733-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF RBM17, HNRNPA2B1, HNRNPA1 ALDH1A1 3613/4885FAAH 4643/4885MAPT 1951/4885
US-20230295617-A1 METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS ELOVL6, ELOVL5, ELOVL1 ALDH1A1 2846/4885FAAH 162/4885MAPT 3184/4885
US-20190249173-A1 METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS ELOVL6, ELOVL5, ELOVL1 ALDH1A1 2811/4885FAAH 163/4885MAPT 2954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.